Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Paul Papin
Angers, France
- Hopital Saint Andre
Bordeaux, France
- Institut Bergonie
Bordeaux, France
- Hopital Ambroise Pare
Boulogne-Billancourt, France
- Centre Regional Francois Baclesse
Caen, France
- Polyclinique Du Parc
Cholet, France
- Centre Hospitalier Universitaire Henri Mondor
Créteil, France
- Clinique Sainte-Marguerite
Hyères, France
- Centre Hospitalier Departemental
La Roche-sur-Yon, France
- Centre Hospital Universitaire Hop Huriez
Lille, France
- Centre Hospital Regional Universitaire de Limoges
Limoges, France
- Polyclinique Des Quatre Pavillons
Lormont, France
- Centre Leon Berard
Lyon, France
- Chu de la Timone
Marseille, France
- Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes
Marseille, France
- Hopital Clinique Claude Bernard
Metz, France
- Hopital Notre-Dame de Bon Secours
Metz, France
- Centre Hospitalier General de Mont de Marsan
Mont-de-Marsan, France
- Centre Regional de Lutte Contre Le Cancer - Centre Val D'Aurelle
Montpellier, France
- Hopital Lapeyronie-Chu Montpellier
Montpellier, France
- Centre Catherine de Sienne
Nantes, France
- Centre Antoine Lacassagne
Nice, France
- Hopital Europeen Georges Pompidou
Paris, France
- Hopital Saint Joseph
Paris, France
- Hopital Tenon
Paris, France
- Hopital de la Croix St. Simon
Paris, France
- Institut Curie Hopital
Paris, France
- Institut Jean Godinot
Reims, France
- Centre Eugene Marquis
Rennes, France
- Centre Hospitalier de Rodez
Rodez, France
- Centre Henri Becquerel
Rouen, France
- Centre Rene Huguenin
Saint-Cloud, France
- Crlcc Nantes - Atlantique
Saint-Herblain, France
- Hopital Foch
Suresnes, France
- Institut Claudius Regaud
Toulouse, France
- Centre Hospitalier Universitaire Bretonneau de Tours
Tours, France
- Centre Alexis Vautrin
Vandœuvre-lès-Nancy, France
- Institut Gustave Roussy
Villejuif, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Nov 2002
- Primary completion
- 21 Dec 2010
- Completion
- 31 Dec 2022
- Last update posted
- 18 Jan 2023
- Registered enrollment
- 413
- Registry id
- NCT00055731
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.